Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors (NETs): a pooled analysis from the randomized, phase 3 RADIANT-3 and RADIANT-4 trials.
Authors
Fazio, NCarnaghi, C
Buzzoni, R
Valle, Juan W
Herbst, F
Ridolfi, A
Strosberg, J
Kulke, M
Pavel, M
Yao, J
Affiliation
European Institute of Oncology, Milan, ItalyIssue Date
2018